# Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells

> **NCT02549625** · PHASE1 · COMPLETED · sponsor: **Timothy J Nelson, MD, PhD** · enrollment: 10 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **BIOLOGICAL:** Autologous Bone Marrow-derived Mononuclear Cells

## Key facts

- **NCT ID:** NCT02549625
- **Lead sponsor:** Timothy J Nelson, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549625, "Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02549625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*